Search alternatives:
significant estimated » significant estimates (Expand Search), significantly mitigated (Expand Search), significantly overestimated (Expand Search)
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
significant estimated » significant estimates (Expand Search), significantly mitigated (Expand Search), significantly overestimated (Expand Search)
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
-
21
-
22
-
23
-
24
-
25
-
26
Scenario analysis for pembrolizumab using a cumulative cost-based price per year per vial.
Published 2024Subjects: -
27
-
28
-
29
-
30
-
31
-
32
Scenario analysis for daratumumab using a cumulative cost-based price per year per vial.
Published 2024Subjects: -
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40